DiaMedica Therapeutics (DMAC) Share-based Compensation (2018 - 2026)
DiaMedica Therapeutics (DMAC) reported Share-based Compensation of $822000.0 for Q1 2026, down 5.19% on a YoY basis from $867000.0 in Q1 2025, and down 31.04% quarter-over-quarter from $1.2 million in Q4 2025.
DiaMedica Therapeutics (DMAC) Share-based Compensation (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Share-based Compensation for 9 years, with the latest figure at $822000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 5.19% year-over-year to $822000.0; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (up 54.26% YoY), and the FY2025 full-year result was $3.8 million, up 84.46% from the prior year.
- Share-based Compensation for Q1 2026 stood at $822000.0, down from $1.2 million in the prior quarter.
- The five-year high for Share-based Compensation was $1.2 million in Q4 2025, with the low at $308000.0 in Q1 2022.
- Historically, Share-based Compensation has averaged $584588.2 across 5 years, with a median of $456000.0 in 2023.
- Annual changes were most pronounced in 2022 — Share-based Compensation sank 39.73% — and 2025, when it soared 102.38%.
- DiaMedica Therapeutics' Share-based Compensation stood at $411000.0 in 2022, then grew by 10.95% to $456000.0 in 2023, then increased by 29.17% to $589000.0 in 2024, then soared by 102.38% to $1.2 million in 2025, then sank by 31.04% to $822000.0 in 2026.
- The last three Share-based Compensation figures came in at $822000.0 (Q1 2026), $1.2 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 26.47 Mn |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | 822,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 822,000.00 |
| Mar 31, 2026 | 822,000.00 |
| Dec 31, 2025 | 1.19 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 771,000.00 |
| Jun 30, 2025 | 771,000.00 |
| Mar 31, 2025 | 867,000.00 |
| Mar 31, 2025 | 867,000.00 |
| Dec 31, 2024 | 589,000.00 |
| Dec 31, 2024 | 589,000.00 |
| Sep 30, 2024 | 565,000.00 |
| Sep 30, 2024 | 565,000.00 |
| Jun 30, 2024 | 443,000.00 |
| Jun 30, 2024 | 443,000.00 |
| Mar 31, 2024 | 488,000.00 |
| Mar 31, 2024 | 488,000.00 |
| Dec 31, 2023 | 456,000.00 |
| Dec 31, 2023 | 456,000.00 |